Please login to the form below
mouth cancer
This page shows the latest mouth cancer news and features for those working in and with pharma, biotech and healthcare.
NICE recommends Ibrance and Lynparza, rejects Keytruda and Xospata
on a number of key cancer drugs, with winners and losers across the board. ... NICE also found issue over a lack of separate clinical evidence for people whose cancer started outside the mouth, and incomplete information regarding Keytruda’s clinical
Latest news
-
NICE set to reject Merck’s Erbitux for head and neck cancer
Merck has since provided further evidence for Erbitux to assist this appraisal process, reducing the indication to patients with mouth cancer alone as well as proposing an additional, undisclosed discount. ... However, the committee said that the new
-
PR and Med Ed news in brief
Mouth Cancer Awareness Week 2004 was the most successful mouth cancer campaign ever said the British Dental Health Foundation.
-
Ethnic Minority Cancer Awareness Week
Sir Trevor McDonald is backing a campaign to raise levels of awareness about the affects of cancer on Black and Minority Ethnic communities. ... of mouth cancer and Bangladeshi and Chinese communities having a higher incidence of liver cancer.
More from news
Approximately 1 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- EU outlines measures to mitigate antibiotic shortage across Europe
- Europe’s cancer community publishes new report on transforming patient care
- Meeting healthcare’s rising challenges
- Diversifying Healthcare AI with Federated Learning
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Tidepool’s automated insulin dosing app for type 1 diabetes gets FDA approval
- UK to introduce new regulatory framework for point of care manufacturing
- Navigating the patient experience to improve retention of clinical trial participants
- Europe’s cancer community publishes new report on transforming patient care
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- EU to revise pharmaceuticals law amid antibiotic shortages
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Why everyone in pharma is bending over backwards to be agile
PMHub
Wisepress
Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
